宾夕法尼亚州第77号法案尽管得到两党的支持,但仍未能停止关闭药店,自2020年以来关闭了1,100多个药店,特别是在农村地区。 Pennsylvania’s Act 77 failed to stop pharmacy closures despite bipartisan backing, with over 1,100 closures since 2020, especially in rural areas.

自2024年《第77号法案》以来,宾夕法尼亚州经历了数百次药店关闭,该法旨在遏制药店福利管理人员的不公平做法,并稳定社区药店。 Pennsylvania has experienced hundreds of pharmacy closures since 2024’s Act 77, a law aimed at curbing unfair practices by pharmacy benefit managers (PBMs) and stabilizing community pharmacies. 尽管两党支持并承诺提高透明度和加强问责制,但该法的影响有限,仅适用于大约24%的州保险市场,而且由于联邦先发制人,不涵盖州外计划。 Despite bipartisan support and promises of greater transparency and accountability, the law’s impact has been limited, applying only to about 24% of the state’s insurance market and not covering out-of-state plans due to federal preemption. 批评者,包括立法者和倡导者说,执法缓慢,偿还率仍然不可持续,掠夺性PBM做法继续发生,特别是在农村地区。 Critics, including lawmakers and advocates, say enforcement has been slow, reimbursement rates remain unsustainable, and predatory PBM practices continue, especially in rural areas. 自2020年以来,1 100多个药店已经关闭,许多药店在第77号法案通过后关闭,干扰了患者获得药物的机会,并引起对长期护理提供情况的关切。 Over 1,100 pharmacies have closed since 2020, with many shutting after Act 77 passed, disrupting patient access to medications and raising concerns about long-term care availability.